Hypothalamus development

pathway activity — cross-omics
GO:0021854Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Hypothalamus development pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are JAM2, ERG, and CAV2, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Hypothalamus development activity versus JAM2 in BRCA (Pearson r = 0.29).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCAJAM2 →+0.523+0.167.006<.00135
BRCAERG →+0.374+0.126.007<.00135
BRCACAV2 →+0.585+0.135.002<.00134
BRCAPPFIBP1 →+0.548+0.145<.001.00334
BRCASPRY2 →+0.726+0.137.004.00434
BRCADNAJB4 →+0.527+0.123<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0021854 vs JAM2 — BRCA

Per-sample scatter of Hypothalamus development activity vs JAM2 in BRCA.

Explore this scatter interactively →

Exploration